STATE CAPITAL INVESTMENT CORPORATION

The Chairman of SCIC’s Board of Directors, Mr. Nguyen Chi Thanh had meeting with Abbott Laboratories Corporation

User Rating: 2 / 5

Star ActiveStar ActiveStar InactiveStar InactiveStar Inactive
 

In the afternoon of 23th February 2023, Mr. Nguyen Chi Thanh – the Chairman of SCIC’s Board of Directors had meeting with Abbott Laboratories Corporation’s delegation crew at SCIC’s headquarters.

The overview of meeting between SCIC and Abbott Laboratories Corporation

 Attending the meeting, from Abbott Laboratories Corporation’s business mission, there are Mr. Sammy G.Karam – Vice President in charge of emerging market of Abbott, Mr. Leonid Goldshteyn – Vice President in charge of Asia – Pacific Region of Abbott, Member of Board of Directors of Domesco Medical Import – Export Joint-Stock Company (Domesco JSC); Regarding Domesco JSC, there is Ms. Luong Thi Huong Giang – Vice President concurrently General Director of Domesco JSC.

Regarding SCIC, attending the meeting, there are Mr. Nguyen Chi Thanh- Chairman of SCIC’s Board of Directors, directors and representatives of functional departments of SCIC.

Mr. Sammy G. Karam – Vice President in charge of emerging market of Abbot Laboratories Corporation expressed appreciation toward SCIC’s support and contribution as the role of shareholder in the corporate governance activities at Domesco JSC in the previous period.

Discussing at the meeting, Mr. Leonid Goldshteyn – Vice President in charge of Asia – Pacific of Abbot Laboratories Corporation, member of Domesco’s Board of Directors discussed many solutions in order to support sustainable development of Domesco JSC in the upcoming time. Accordingly, Abbot Laboratories Corporation is willing to aid Domesco enhance production capacity of existing factories by EU-GMP standards, transfer new types of medicine’ licenses which are suitable to Vietnam pharmacy market. Besides, Abbot Laboratories Corporation will continue assist Domesco in activities of corporate governance, financial management and training, upgrading staff competencies; with the purpose of improving production capacity of the enterprises, managing skills and expertise of employees, contributing to uplifting competitive competencies of Domesco in the Vietnam pharmacy market and striving to exporting internationally standardized quality medicines products to foreign markets in the future.

Mr. Leonid Goldshteyn – Vice President in charge of Asia – Pacific region of Abbot Laboratories Corporation, Member of Domesco’s Board of Directors also evaluate that Vietnam market converges competitive advantages for researches and developing high quality pharmacy products such as available material sources, high-quality human resources, reasonable costs, good geography location…; with those strengths, local pharmacy enterprises have had powerful growths in scale , portfolio of high-quality pharmacy products and gained significant development.

Representing SCIC, Mr. Nguyen Chi Thanh – Chairman of SCIC’s BOD agreed with Mr. Leonid Goldshteyn’s opinions about development trends of pharmacy industry in Vietnam. Besides, the Chairman of SCIC’s BOD, Mr. Nguyen Chi Thanh also stated that in the context of increasing significantly competitiveness of local pharmacy industry, especially many local pharmacy firms have gained high growth quickly in the previous period, in order to maintain firmly market share in Vietnam, Domesco need to strive more to achieve higher growth rate compared to average growth rate of the industry. The Chairman of SCIC’s BOD, Mr. Nguyen Chi Thanh suggested some new cooperation methods between SCIC and Abbot Laboratories Corporation so that both parties together do research, including considering possibility in investment cooperation of building Vietnam pharmacy production plants according to pharmacy industry developing strategy ( By Decision No 376/QD-TTg dated 17th March 2021 of Prime Minister, Project of Industrial zones in the North, Middle, South with the content of building new infrastructures which helps attracting FIE investors to transfer producing technology for innovator pharmaceutical products, generic dispensed vaccine originating products, medical biological products, high value biological medicines according to portfolio of key projects calling for investment).

SCIC and Abbot Laboratories Corporation take picture.

Ending the meeting, representatives of SCIC and Abbot Laboratories Corporation agreed that both parties would continue to maintain and develop bilateral fruitful relationship and together consider suitable investment cooperation opportunities with both parties’ criteria and benefits.  

 


ABOUT US
Leadership

Mr Nguyen Chi Thanh

Chairman of the Board of Members

Mr Nguyen Quoc Huy

Board Member, General Director

Mr Le Huy Chi

Board Member

Ms Dinh Thi Bich Diep

Board Member

Mr Dinh Viet Tung

Deputy General Director

Mr Nghiêm Xuân Đa

Deputy General Director

Mr Lê Thanh Tuấn

Deputy General Director

Mr Vu Tri Thuc

Chief Accountant

Mr Chu Thanh Long

Supervisor

Mr Thoi Van Tan

Supervisor

Mr Nguyen Duc Nam

Supervisor
Our vision
Our mission
Information disclosure
LINKS WEBSITE
Image
Image
Image
Image
Image
Image
Image
Image
State Capital Investment Corporation (SCIC). Address: Level 23-24 Charmvit Tower, 117 Tran Duy Hung St., Cau Giay Dist., Hanoi. License: No. 338/GP-BC dated November 10th, 2006. Website: www.scic.vn